BioSpace News Archive

PharmaMar (MCE: PHM), today announced it will be featured as a presenting company at the 17th Needham & Co Annual Healthcare Conference.

7SIGNAL announced today that it has closed a $7 million Series C financing round.

Kemin Industrie has released a novel study on the interaction of non-starch polysaccharides from wheat with the addition of feed enzymes, such as KEMZYME®.

Stephen Sofen, Ph.D. to head technical operations and Susan Stewart, J.D. to lead regulatory affairs and quality

Silk Road Medical, Inc., a company dedicated to preventing the devastating burden of stroke through surgical innovation, today announced that medical device industry veteran Donald J. Zurbay has joined its board of directors.

Gum tissue repairs itself roughly twice as fast as skin and with reduced scar formation.

RXi Pharmaceuticals Corporation reported its financial results for the fourth quarter and year ended December 31, 2017 and provided a business update.

In a recent op-ed in Fortune, Joe Biden expounded upon his call to improve access to healthcare information for patients.

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has refinanced its existing $1.0 billion of revolving credit facility due 2021 with a new $1.55 billion revolving credit facility due 2023, and its existing $650.0 million of term loan facility due 2021 with a new $750.0 million term loan facility due 2023 (the “credit facilities”).

Boehringer Ingelheim, KMOH, and ZNWT establish a vaccine joint venture targeting foot-and-mouth disease control and prevention in China; The vaccine manufacturing project is located at the Airport New City in Xi’an with a total investment of 840 million yuan (around €108 million); The venture will introduce the world’s leading vaccine technology and expertise against foot-and-mouth disease in a bid to shape the future market in China